Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.
LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function (ADCS-ADL23) In pre-specified subgroups of patients with moderate Alzheimer’s...
Topline data from completed Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease targeted for September 2024 Phase 2/3 LIFT-AD data to...
Fosgonimeton mitigated amyloid-β-induced toxicity, lowered pTau levels and reduced disruption of protein clearance mechanisms that may contribute to pTau pathology Fosgonimeton treatment, alone...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.465 | -82.1666666667 | 3 | 3.67 | 0.4649 | 1804751 | 0.92091976 | CS |
4 | -1.735 | -76.4317180617 | 2.27 | 3.67 | 0.4649 | 676467 | 1.16212776 | CS |
12 | -1.985 | -78.7698412698 | 2.52 | 3.67 | 0.4649 | 428607 | 1.51953982 | CS |
26 | -1.525 | -74.0291262136 | 2.06 | 4.2984 | 0.4649 | 362665 | 1.98812051 | CS |
52 | -10.495 | -95.1495920218 | 11.03 | 16.65 | 0.4649 | 375221 | 4.67288687 | CS |
156 | -19.415 | -97.3182957393 | 19.95 | 34.79 | 0.4649 | 423417 | 8.35039753 | CS |
260 | 0 | 0 | 0 | 0.5796 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관